Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. The decades-long push to develop an HIV vaccine has been riddled with setbacks. But ...

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and antibodies. In most vaccines, HIV proteins are attached to a larger protein ...

Add Yahoo as a preferred source to see more of our stories on Google. Messenger RNA, full name messenger ribonucleic acid, is a molecule in the body that carries instructions to make proteins. “To ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. Scientists have been developing mRNA vaccines against HIV, with one approach recently showing ...

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given. HARARE, ZIMBABWE, ROME, ITALY, NEW YORK, NY, AND CAMBRIDGE, MA / ACCESS ...

After decades of research, there is still no cure for the disease HIV causes–AIDS. Each year, HIV infects more than one million people worldwide, and a vaccine remains stubbornly out of reach. Hope, ...

Scientists have designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus. One of the biggest hurdles in developing an HIV vaccine is ...

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that just a single dose can provide strong protection from HIV. Vaccines ...

The closest thing we have to an HIV vaccine has hit the market – but less than a tenth of the doses needed to change the course of the pandemic will reach the people who need them, new figures suggest ...

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...